Clinical Trials
265 trialsDose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
Memorial Sloan Kettering Cancer Center
RF-2018-123683
IRCCS San Raffaele
NABPLAGEMD
HonorHealth Research Institute
NOAHS-ARC
Servicio de Salud Metropolitano Sur Oriente
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
University of Southern California
EVENTIDE
University of Aberdeen
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
University of Birmingham
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
IGASSU
Centre Oscar Lambret
CHIMTEP
Centre Oscar Lambret
Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction
Ankara University
Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery
Incheon St.Mary's Hospital
PREACT
Shanghai Cancer Hospital, China
FIRSTLUNG
Delfi Diagnostics Inc.
Cabozantinib and Pembrolizumab in Metastatic Pancreas
University of Kentucky
ARION
UNICANCER
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy
Regeneron Pharmaceuticals
NeoResII
Karolinska University Hospital
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
University of Iowa
POELH-II
Erasmus Medical Center
A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia
AstraZeneca
PCW
Wake Forest University Health Sciences
CART-meso in Mesothelin Expressing Cancers
University of Pennsylvania
CABATEN
Grupo Espanol de Tumores Neuroendocrinos
Bethanechol Prior to Pancreatic Surgery
Columbia University
ARROW
Hoffmann-La Roche
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Immuneering Corporation
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
Memorial Sloan Kettering Cancer Center
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Imugene Limited
NICE
Eurofarma Laboratorios S.A.
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Osteosclerotic Changes on CT Predict Survival in Prostate Cancer
Sun Yat-sen University
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology
National Institutes of Health Clinical Center (CC)
Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Genetic Studies of Prostate Cancer Aggressiveness and Prognosis
Karolinska Institutet
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ROOT
Taproot Health
Investigation of the Diagnostic Role of miRNAs in PCa and BPH
Alanya Alaaddin Keykubat University
Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
Astellas Pharma Inc
DG-06
AstraZeneca
A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Inc
Androgen Deprivation Therapy in Advanced Salivary Gland Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
Memorial Sloan Kettering Cancer Center